Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment

Cancer immunotherapy can induce sustained responses in patients with cancers in a broad range of tissues, however, these treatments require the optimized combined therapeutic strategies. Despite immune checkpoint inhibitors (ICIs) have lasting clinical benefit, researchers are trying to combine them...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Juan-Yan, Zhang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193725/
https://www.ncbi.nlm.nih.gov/pubmed/34123821
http://dx.doi.org/10.3389/fonc.2021.663264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193725/
https://www.ncbi.nlm.nih.gov/pubmed/34123821
http://dx.doi.org/10.3389/fonc.2021.663264

Ejemplares similares